Ipatasertib in Combination With Carboplatin, Carboplatin/Paclitaxel, or Capecitabine/Atezolizumab in Treating Patients With Metastatic Triple Negative Breast Cancer

NCT03853707 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Triple-Negative Breast Carcinoma
Prognostic Stage IV Breast Cancer AJCC v8

Interventions

DRUG: Atezolizumab
DRUG: Capecitabine
DRUG: Carboplatin
DRUG: Ipatasertib
DRUG: Paclitaxel
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration

Sponsor

City of Hope Medical Center

Collaborators

[object Object]